2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 351.072 | 348.225 | 355.694 | 367.931 | 374.695 | 429.587 | 550.690 | 496.885 | 619.375 | 720.142 |
Total Income - EUR | 351.113 | 349.909 | 357.287 | 367.960 | 374.700 | 440.822 | 550.698 | 496.895 | 619.429 | 720.166 |
Total Expenses - EUR | 328.021 | 331.215 | 320.641 | 340.975 | 344.166 | 399.748 | 490.914 | 451.937 | 560.090 | 669.765 |
Gross Profit/Loss - EUR | 23.092 | 18.694 | 36.646 | 26.985 | 30.534 | 41.074 | 59.784 | 44.958 | 59.340 | 50.400 |
Net Profit/Loss - EUR | 18.391 | 14.415 | 30.668 | 23.056 | 26.787 | 36.666 | 55.702 | 40.586 | 53.455 | 43.656 |
Employees | 5 | 6 | 6 | 7 | 8 | 8 | 8 | 8 | 8 | 8 |
Check the financial reports for the company - C B Farmalis Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 21.653 | 18.252 | 17.451 | 13.571 | 10.907 | 10.452 | 9.667 | 7.268 | 28.383 | 22.338 |
Current Assets | 185.058 | 182.346 | 157.757 | 182.067 | 173.752 | 218.952 | 242.199 | 205.577 | 249.999 | 308.415 |
Inventories | 34.720 | 41.843 | 56.678 | 56.707 | 53.147 | 75.713 | 80.862 | 77.300 | 82.127 | 92.726 |
Receivables | 82.978 | 57.083 | 34.379 | 67.012 | 74.316 | 79.113 | 96.923 | 95.612 | 118.513 | 144.859 |
Cash | 67.359 | 83.420 | 66.699 | 58.347 | 46.289 | 64.125 | 64.413 | 32.665 | 49.358 | 70.830 |
Shareholders Funds | 98.863 | 91.607 | 65.671 | 57.467 | 60.566 | 68.285 | 86.741 | 84.973 | 87.997 | 131.386 |
Social Capital | 67 | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 |
Debts | 107.847 | 108.991 | 109.537 | 138.171 | 124.093 | 161.119 | 165.124 | 127.872 | 190.385 | 199.367 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - C B Farmalis Srl